An analysis of geometric uncertainty calculations for prostate radiotherapy in clinical practice

British Journal of Radiology

Volumn 82, Issue 974, 2009, Pages 140-147

  Mcgarry, C K ^a   Cosgrove, V P ^a   Fleming, V A L ^a   O'Sullivan, J M ^a,b   Hounsell, A R ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; DIAGNOSTIC ERROR; DOSE CALCULATION; GEOMETRY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MEDICAL AUDIT; PATHOLOGICAL ANATOMY; PREOPERATIVE RADIOTHERAPY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RADIATION DOSE; SIMULATION; UNCERTAINTY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; MEDICAL ERROR; METHODOLOGY; MULTICENTER STUDY; PROSTATE TUMOR; RADIOGRAPHY; RADIOLOGY; STANDARD;

HUMANS; MALE; MEDICAL AUDIT; MEDICAL ERRORS; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TECHNOLOGY, RADIOLOGIC; TOMOGRAPHY, X-RAY COMPUTED; UNCERTAINTY;

EID: 61449179450     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/20582161     Document Type: Article

References (36)

1. International Commission on Radiation Units and Measurements. ICRU report 50: Prescribing, recording, and reporting photon beam therapy. Bethesda, MD: International Commission on Radiation Units and Measurements, 1993.
2. International Commission on Radiation Units and Measurements. ICRU report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Bethesda, MD: International Commission on Radiation Units and Measurements, 1999.
3. Van Herk M, Remeijer P, Rasch C, Lebesque JV. Probability of correct dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1121-35.
4. BIR Working Party. Geometric uncertainties in radiotherapy. London, UK: The British Institute of Radiology, 2003.
5. Van Herk, Errors and margins in radiotherapy. Sem Radiat Oncol 2004;14:52-64.
6. Bijhold J, van Herk M, Vijlbrief R, Lebesque JV. Fast evaluation of patient set-up during radiotherapy by aligning features in portal and simulator images. Phys Med Biol 1991;36:1665-79.
7. Mubata CD, Bidmead AM, Ellingham LM, Thompson V, Dearnaley DP. Portal imaging protocol for radical doseescalated radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1998;40:221-31.
8. Herman MG. Clinical use of electronic portal imaging. Semin Radiat Oncol 2005;15:157-67.
9. Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999;43:57-66.
10. Langen KM, Jones DT. Organ motion and its management. Int J Radiat Oncol Biol Phys 2001;50:265-78.
11. Wu J, Haycocks T, Alasti H, Ottewell G, Middlemiss N, Abdolell M, et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 2001;61:127-33.
12. Nederveen AJ, Dehnad H, van der Heide UA, van Moorselaar RJ, Hofman P, Lagendijk JJ. Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. Radiother Oncol 2003;68:81-8.
13. Hoogeman MS, van Herk, de Bois J, Lebesque JV. Stratagies to reduce the systematic error due to tumour and rectum motion in radiotherapy of prostate cancer. Radiotherapy and Oncology 2005;74:177-85.
14. Hurkmans CW, Remeijer P, Lebesque JV, Mijnheer BJ. Set-up verification using portal imaging: review of current clinical practice. Radiother Oncol 2001;58:105-20.
15. Kitamura K, Shirato H, Seppenwoolde Y, Onimaru R, Oda M, Fujita K, et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys 2002;53:1117-23.
16. Malone S, Crook JM, Kendal WS, Szanto J. Respiratoryinduced prostate motion: quantification and characterization. Int J Radiat Oncol Biol Phys 2000;48:105-9.
17. Nichol AM, Brock KK, Lockwood GA, Moseley DJ, Rosewall T, Warde PR, et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys 2007;67:48-56.
18. Schallenkamp JM, Herman MG, Kruse JJ, Pisansky TM. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 2005;63:800-11.
19. Enmark E, Korreman S, Nystrom H. IGRT of prostate cancer; is the margin reduction gained from daily IG timedependent? Acta Oncologica 2006;45:907-14.
20. van Herk M, Bruce A, Kroes AP, Shouman T, Touw A, Lebesque JV. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 1995;33:1311-20.
21. Bel A, van Herk M, Lebesque JV. Target margins for random geometrical treatment uncertainties in conformal radiotherapy. Med Phys 1996;23:1537-45.
22. Bel A, Vos, PH, Rodrigus PTR, Creutzberg CL, Visser AG, Stroom JC et al. High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiation Oncology Biol Phys 1996;35:321-32.
23. Van Herk M, Remeijer P, Lebesque JV. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys 2002;52:1407-22.
24. Craig T, Wong E, Bauman G, Battista J, Van Dyk J. Impact of geometric uncertainties on evaluation of treatment techniques for prostate cancer. Int J Radiat Oncol Biol Phys 2005;62:426-36.
25. Peeters ST, Hoogeman MS, Heemsbergen WD, Slot A, Tabak H, Koper PC, et al. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2005;63:1142-52.
26. Livsey JE, Wylie JP, Swindell R, Khoo VS, Cowan RA, Logue JP. Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity? Int J Radiat Oncol Biol Phys 2004;60:1076-81.
27. Landoni V, Saracino B, Marzi S, Gallucci M, Petrongari MG, Chianese E, et al. A study of the effect of set-up errors and organ motion on prostate cancer treatment with IMRT. Int J Radiat Oncol Biol Phys 2006;65:587-94.
28. Seddon B, Bidmead M, Wilson J, Khoo V, Dearnaley D. Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial. Radiother Oncol 2000;56:73-83.
29. Happersett L, Mageras GS, Zelefsky MJ, Burman CM, Leibel SA, Chui C, et al. A study of the effects of internal organ motion on dose escalation in conformal prostate treatments. Radiother Oncol 2003;66:263-70.
30. Bayley AJ, Catton CN, Haycocks T, Kelly V, Alasti H, Bristow R, et al. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol 2004;70:37-44.
31. Stasi M, Munoz F, Fiorino C, Pasquino M, Baiotto B, Marini P, et al. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer. Radiother Oncol 2006;80:363-70.
32. Wu J, Haycocks T, Alasti H, Ottewell G, Middlemiss N, Abdolell M, et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 2001;61:127-33.
33. Sydes MR, Stephens RJ, Moore AR, Aird EG, Bidmead AM, Fallowfield LJ, et al. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer. Radiother Oncol 2004;72:199-211.
34. Van den Heuvel F, Fugazzi J, Seppi E, Forman JD. Clinical application of a repositioning scheme, using gold markers and electronic portal imaging. Radiother Oncol 2006;79: 94-100.
35. Wu Q, Ivaldi G, Liang J, Lockman D, Yan D, Martinez A. Geometric and dosimetric evaluations of an online imageguidance strategy for 3D-CRT of prostate cancer. Int J Radiat Oncol Biol Phys 2006;64:1596-609.
36. Litzenberg DW, Balter JM, Lam KL, Sandler HM, Ten Haken RK. Retrospective analysis of prostate cancer patients with Implanted gold markers using off-line and adaptive Therapy protocols. Int J Radiation Oncology Biol Phys 2005;63:123-33.